Mayne Pharma Group Ltd has released a press release.
Preliminary Final Report
Filed with ASX ·
Watch Mayne Pharma's latest callMayne Pharma Group (ASX:MYX) Q4 2026 Earnings Call · Replay · Aug 26Read the transcript of Mayne Pharma Group (ASX:MYX) Q4 2026 Earnings Call6ix hasn’t read this filing yet.
Mayne Pharma Group Ltd. on 6ix
In the deck
Earlier from Mayne Pharma
- MYX provides investor update & announces on market buyback
- Mayne Pharma May 2023 market update presentation
- MYX completes sale of US retail generics business for US$90m
- Update on sale of US retail generics portfolio
- Mayne Pharma announces cancellation of capital return
Later from Mayne Pharma
- 2023 Full Year Results Media Release
- 2023 Full Year Results Investor Presentation
- Mayne Pharma provides update on 1Q FY24 trading and outlook
- Mayne Pharma provides update on first quarter 2024 trading and outlook
- Issuance of additional US Patent for NEXTSTELLIS
Follow Mayne Pharma into a list and get an email when it puts out news.
Follow Mayne Pharma